Transdermal iontophoretic delivery of [3h]ghrp in rats

International Journal of Pharmaceutics

Volumn 159, Issue 1, 1997, Pages 1-11

  Ellens, Harma ^a   Lai, Ziping ^b   Marcello, Joe ^a   Davis, Charles B ^a   Cheng, Hung Yuan ^a   Oh, Choon K ^a   Okabe, Keiichiro ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Advance Co   (Japan)

Author keywords

3H GHRP; Growth hormone releasing peptide; Iontophoresis; Peptide delivery; Transdermal delivery

Indexed keywords

HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEVICE; DRUG BILE LEVEL; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG URINE LEVEL; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0344043301     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00268-8     Document Type: Article

References (27)

1. Bowers C.Y., Momany F.A., Reynolds G.A., Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 114:1984;1537-1545.
2. Bowers C.Y., Reynolds G.A., Durham D., Barrera C.M., Pezzoli S.S., Thorner M.O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab. 70:1990;975-982.
3. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′, 5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology. 124:1989;2791-2798.
4. Chien Y.W., Lelawongs P., Siddiqui O., Sun Y., Shi W.M. Facilitated transdermal delivery of therapeutic peptides and proteins by iontophoretic delivery devices. J. Controlled Rel. 13:1990;263-278.
5. Clark R.G., Carlsson L.M.S., Trojnar J., Robinson I.C.A.F. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anesthetized rats. J. Neuroendocrinol. 1:1989;249-255.
6. Davis C.B., Crysler C.S., Boppana V.K., Fong K.-L., Joseph G.L., Urbanski J.J., Macia R.A., Rhodes G.R. Disposition of growth hormone-releasing peptide (SK&F 110 679) in rat and dog following intravenous or subcutaneous administration. Drug Metab. Disposition. 22:1994;90-98.
7. DeBell W.K., Pezzoli S.S., Thorner M.O. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation. J. Clin. Endocrinol. Metab. 72:1991;1312-1316.
8. Delgado-Charro M.B., Guy R.H. Iontophoretic delivery of nafarelin across the skin. Int. J. Pharm. 117:1995;165-172.
9. Edman P., Bjork E. Nasal delivery of peptide drugs. Adv. Drug Del. Rev. 8:1992;165-177.
10. Green P., Shroot B., Bernerd F., Pilgrim W.R., Guy R.H. In vitro and in vivo iontophoresis of a tripeptide across nude rat skin. J. Controlled Rel. 20:1992;209-218.
11. Hadgraft, J., Guy, R.H. (Eds.), 1989. Transdermal Drug Delivery. Marcel Dekker, New York.
12. 2 (growth hormone releasing peptide) increased plasma growth hormone and insulin-like growth factor-I levels in normal men. Endocrinol. Jpn. 38(1):1991;15-21.
13. Ishii, M., Tochikubo, O., Sesoko, S., Seo, I., Konno, T., Sasaki, M., Okabe, K., 1992. A new transdermal delivery system of synthetic thyrotropin-releasing hormone by means of iontophoresis in healthy volunteers. 5th World Conf. Clinical Pharmacology and Therapeutics, Yokohama, Japan (Abstract).
14. Issaurat B., Teissie J. Interaction between a growth hormone releasing hexapeptide and phospholipids spread as monolayers at the air/water interface. Biochim. Biophys. Acta. 944:1988;516-520.
15. Iwakura Y., Morimoto K. Transdermal iontophoretic delivery of vasopressin and its analogues in rats. STP Pharm. Sci. 1:1991;387-390.
16. Kari B. Control of blood glucose levels in alloxan-diabetic rats by iontophoresis of insulin. Diabetes. 35:1986;217-221.
17. Kumar S., Char H., Patel S., Piemontese D., Malick A.W., Iqbal K., Neugroschel E., Behl C.R. In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1-44) in hairless guinea pigs. J. Controlled Rel. 18:1992;213-220.
18. Lelawongs P., Liu J.-C., Siddiqui O., Chien Y.W. Transdermal iontophoretic delivery of arginine-vasopressin (I): physicochemical considerations. Int. J. Pharm. 56:1989;13-22.
19. Meyer B.R., Kreis W., Eschbach J., O'Mare V., Rosen S., Sibalis D. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers. Clin. Pharmacol. Ther. 44:1988;607-612.
20. Miller L.L., Kolaskie C.J., Smith G.A., Rivier J. Transdermal iontophoresis of gonadotropin releasing hormone (LHRH) and two analogues. J. Pharm. Sci. 79(6):1990;490-493.
21. Okabe K., Yamaguchi H., Kawai Y. New iontophoretic transdermal administration of the beta blocker metoprolol. J. Controlled Rel. 4:1986;79-85.
22. Patton J.S., Platz R.M. Pulmonary delivery of peptides and proteins for systemic action. Adv. Drug Del. Rev. 8:1992;179-196.
23. Siddiqui O., Sun Y., Liu J.C., Chien Y.W. Facilitated transdermal transport of insulin. J. Pharm. Sci. 76:1987;341-345.
24. Singh P., Maibach H.I. Transdermal iontophoresis, pharmacokinteic considerations. Clin. Pharmacokinet. 26(5):1994;327-334.
25. Smith P.L., Yeulet S.E., Citerone D.R., Drake F., Cook M., Wall D.A., Marcello J. SK&F 110 679: Comparison of absorption following oral or respiratory administration. J. Controlled Rel. 28:1994;67-77.
26. Wearly L., Liu J.C., Chien Y.W. Iontophoresis-facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability. J. Controlled Rel. 9:1989;231-242.
27. Winer L.M., Shaw M.A., Baumann G. Basal plasma growth hormone levels in man: new evidence for rythmicity of growth hormone secretion. J. Clin. Endocrinol. Metab. 70:1990;1678-1686.